Similarly, Oncofetal antigens which are CAAs include PSA, AFP, and WT1, and it is reported that T cells targeting WTI prevented AML relapse post-transplant with 100% relapse-free survival at a median of 44 months following infusion, showing promise for preventing AML recurrence [39]. This evidence concerns the gene WT1 and acute myeloid leukemia.